Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–17 of 17 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
- Conditions
- Adenocarcinoma, Adnexal Diseases, Amyloidosis, +130 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT07277413
- Conditions
- Adenocarcinoma Of Esophagus, Adenocarcinoma of Esophagus, Adenoma, +55 more
- Locations
-
- Providence Medical Foundation Santa Rosa, California, United States
- Johns Hopkins Sibley Memorial Hospital Washington D.C., District of Columbia, United States
- BRCR Global-Coral Springs Coral Springs, Florida, United States
- Sarah Cannon Research Institute at Florida Cancer Specialists Orlando, Florida, United States
NCT07099547
- Conditions
- Biliary Tract Carcinoma
- Locations
-
- The First Affiliated Hospital of University of Science and Technology of China Hefei, Anhui, China
NCT05668884
- Conditions
- Biliary Tract Carcinoma
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
NCT06168292
- Conditions
- Biliary Tract Carcinoma, Radio-frequency Ablation, Radiotherapy
- Locations
-
- National Cancer Center, Korea Goyang-si, Other, South Korea
- Conditions
- Adenocarcinoma, Biliary Tract Carcinoma, Carcinoma, +12 more
- Locations
-
- Zhengjiang Cancer Hospital Hangzhou, Zhejiang, China
Not Yet Recruiting
A Trial of Recaticimab and Adebrelimab in Combination With Chemotherapy in Patients With Unresectable BTC
NCT07062328
- Conditions
- Biliary Tract Carcinoma
- Locations
-
Not specified
Not Yet Recruiting
Irinotecan Liposomes +5-FU/LV Versus Capecitabine in Patients of Recurrence After Resection of Resectable BTC
NCT06699459
- Conditions
- Biliary Tract Carcinoma
- Locations
-
- Fujian Provincial Hospital Fuzhou, Fujian, China
- The First Affiliated Hospital, Sun Yat-sen University Guangzhou, Guangdong, China
- Renji Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
- Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Pemigatinib Combined With Durvalumab for Previously Treated Biliary Tract Carcinoma
NCT06530823
- Conditions
- Adenocarcinoma, Biliary Tract Carcinoma, Carcinoma, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Irinotecan Hydrochloride Liposome Combined With Capecitabine and Lenvatinib in Patients With Biliary Tract Carcinoma
NCT06463548
- Conditions
- Biliary Tract Carcinoma
- Locations
-
- The First Hospital of China Medical University Shenyang, China
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- Anhui Provincial Hospital ( Site 0140) Hefei, Anhui, China
- Beijing Cancer Hospital ( Site 0138) Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital ( Site 0150) Beijing, Beijing Municipality, China
- First Affiliated Hospital of The Third Military Medical University ( Site 0130) Chongqing, Chongqing Municipality, China
NCT04003636
- Conditions
- Adenocarcinoma, Bile Duct Diseases, Bile Duct Neoplasms, +14 more
- Locations
-
- University of Alabama at Birmingham Comprehensive Cancer Ctr ( Site 0016) Birmingham, Alabama, United States
- University of California San Diego Moores Cancer Center ( Site 0008) La Jolla, California, United States
- UCLA Hematology/Oncology - Santa Monica ( Site 0014) Los Angeles, California, United States
- University of California - San Francisco ( Site 0030) San Francisco, California, United States
Completed
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
NCT04067960
- Conditions
- Adnexal Diseases, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +82 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
Completed
A Study of Merestinib (LY2801653) in Japanese Participants With Advanced or Metastatic Cancer
NCT03027284
- Conditions
- Adenocarcinoma, Advanced Cancer, Biliary Tract Carcinoma, +27 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician Tokyo, Japan
NCT00490399
- Conditions
- Biliary Tract Carcinoma
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Seoul, South Korea
Active, Not Recruiting
Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
NCT06048133
- Conditions
- Adenocarcinoma, Bile Duct Cancer, Bile Duct Diseases, +12 more
- Locations
-
- Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
- University of Michigan Health System Ann Arbor, Michigan, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- University of Wisconsin Madison, Wisconsin, United States
Active, Not Recruiting
A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer
NCT02151084
- Conditions
- Biliary Tract Carcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +11 more
- Locations
-
- Princess Margaret Cancer Centre Toronto, Ontario, Canada